Saturday, January 29, 2022

INMAS

DRDO’s 2-DG drug to help combat Covid

The drug can be added as a supplement or adjunct to the existing treatment protocols to treat moderate to severe Covid patients

Hyderabad drives innovation for Covid therapies

The latest therapy with links to the city is the glucose molecule 2-DG and its anti-Covid-19 therapeutic application that was given a green signal by Indian drug regulatory authorities

DCGI approves anti-COVID drug developed by DRDO for emergency use

The drug has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of Defence Research and Development Organisation (DRDO).

Latest News

- Advertisement -